Patents by Inventor Sridhar Viswanathan
Sridhar Viswanathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230179672Abstract: Aspects of the disclosure relate to generating and providing enhanced user interfaces by implementing data, AI, intents and personalization (DAIP) technology. In some embodiments, a computing platform may receive, from enterprise computing infrastructure, first unstructured activity data associated with a first enterprise channel. Subsequently, the computing platform may identify one or more user intents by applying an intent discovery model to the first unstructured activity data associated with the first enterprise channel. Then, the computing platform may generate status tracking information based on identifying the one or more user intents.Type: ApplicationFiled: December 2, 2021Publication date: June 8, 2023Inventors: Prashanth Vallabhaneni, Diane S. Cannato, Rosheny Edathil, Satyabrata Pradhan, Sridhar Viswanathan, Ashwin Kumar Yedte
-
Publication number: 20210317188Abstract: The invention provides a composition including an intact activatable antibody and a clipped variant thereof, methods of separating clipped variants of intact activatable antibodies from intact activatable antibodies and related methods including methods for determining or monitoring a relative percentage of an activatable antibody and a clipped variant thereof during a composition production process.Type: ApplicationFiled: April 9, 2021Publication date: October 14, 2021Applicant: CytomX Therapeutics, Inc.Inventors: Sarah PATRICK, Claus KREBBER, Sridhar VISWANATHAN, Shanti Gonela DUVUR, Eric URENO
-
Publication number: 20100260759Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.Type: ApplicationFiled: April 20, 2010Publication date: October 14, 2010Applicant: PERSEID THERAPEUTICS LLCInventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin, Sridhar Viswanathan, Brent R. Larsen
-
Publication number: 20090258031Abstract: The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.Type: ApplicationFiled: October 15, 2008Publication date: October 15, 2009Applicant: MAXYGEN, INC.Inventors: Erik E. Karrer, Madan M. Paidhungat, Steven H. Bass, Margaret Neighbors, Juha Punnonen, Steven J. Chapin, Sridhar Viswanathan, Brent R. Larsen
-
Patent number: 7541163Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: August 14, 2007Date of Patent: June 2, 2009Assignees: Maxygen, Inc., Roche Palo Alto LLCInventors: Phillip A. Patten, Sridhar Viswanathan, Torben Lauesgaard Nissen, Anne Vogt, Harald Kropshofer, Ralf Schumacher, Stephan Fischer, Stefan Seeber, Adelbert Grossmann, Friederike Hesse
-
Patent number: 7541436Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: May 4, 2007Date of Patent: June 2, 2009Assignees: Maxygen, Inc., Roche Palo Alto LLCInventors: Phillip A. Patten, Sridhar Viswanathan, Torben Lauesgaard Nissen, Anne Vogt, Harald Kropshofer, Ralf Schumacher, Stephan Fischer, Stefan Seeber, Andreas Schaubmar, Hans Koll
-
Patent number: 7537755Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: August 15, 2007Date of Patent: May 26, 2009Assignees: Maxygen, Inc., Roche Palo Alto LLCInventors: Phillip A. Patten, Sridhar Viswanathan, Torben Lauesgaard Nissen, Anne Vogt, Harald Kropshofer, Ralf Schumacher, Stephan Fischer, Stefan Seeber, Andreas Schaubmar, Hans Koll
-
Patent number: 7531324Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: September 13, 2006Date of Patent: May 12, 2009Assignee: Maxygen, Inc.Inventors: Phillip A. Patten, Sridhar Viswanathan, Torben Lauesgaard Nissen, Anne Vogt, Harald Kropshofer, Ralf Schumacher, Stephan Fischer, Stefan Seeber, Andreas Schaubmar, Roberto Falkenstein
-
Patent number: 7531630Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: September 13, 2006Date of Patent: May 12, 2009Assignee: Maxygen, Inc.Inventors: Phillip A. Patten, Sridhar Viswanathan, Torben Lauesgaard Nissen, Anne Vogt, Harald Kropshofer, Ralf Schumacher, Stephan Fischer, Stefan Seeber, Andreas Schaubmar, Hans Koll
-
Publication number: 20090093616Abstract: The present invention is directed to a method for activation of Factor VII to FVIIa in solution.Type: ApplicationFiled: May 27, 2008Publication date: April 9, 2009Inventors: Claus M. Krebber, Sridhar Viswanathan
-
Patent number: 7504097Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: October 30, 2006Date of Patent: March 17, 2009Assignee: Maxygen, Inc.Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Patent number: 7498152Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: October 30, 2006Date of Patent: March 3, 2009Assignee: Maxygen, Inc.Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Publication number: 20090042252Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: ApplicationFiled: October 30, 2006Publication date: February 12, 2009Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Patent number: 7488473Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: October 30, 2006Date of Patent: February 10, 2009Assignee: Maxygen, Inc.Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Patent number: 7488801Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: October 30, 2006Date of Patent: February 10, 2009Assignee: Maxygen, Inc.Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Patent number: 7488589Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: GrantFiled: October 30, 2006Date of Patent: February 10, 2009Assignee: Maxygen, Inc.Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Publication number: 20090017500Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: ApplicationFiled: October 30, 2006Publication date: January 15, 2009Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Publication number: 20090017501Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: ApplicationFiled: October 30, 2006Publication date: January 15, 2009Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Publication number: 20090017502Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: ApplicationFiled: October 30, 2006Publication date: January 15, 2009Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen
-
Publication number: 20090011465Abstract: The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.Type: ApplicationFiled: October 30, 2006Publication date: January 8, 2009Inventors: Phillip A. Patten, Sridhar Govindarajan, Sridhar Viswanathan, Torben Lauesgaard Nissen